Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06671002Phase 4
Key facts
Phase 4, randomised, open-label trial of morphine in postoperative pain (2 arms), sponsored by University of Michigan. Primary endpoints: Brief Pain Inventory pain intensity score at 12 months and Number and severity of any adverse medication-related symptoms at 1 month. Started Jan 2025; status: recruiting.
Acetaminophen/NSAID regimen
Participants receive Acetaminophen and an NSAID (Ibuprofen or Celecoxib).
Acetaminophen/NSAID/Opioid regimen
Participants receive Acetaminophen, an NSAID (Ibuprofen), and an Opioid (Oxycodone or Hydromorphone).
Children undergoing tonsil removal, gallbladder removal, or knee scope, without significant prior opioid use, complex chronic conditions, liver disease, or acute psychiatric instability.
Brief Pain Inventory pain intensity score
Number and severity of any adverse medication-related symptoms
PROMIS Pediatric Sleep Disturbance v1.0 short form 4a
Patient Global Impression of Change
PROMIS Pediatric Pain Interference scale (Short form-8a)
Pain Catastrophizing Scale
Pediatric Quality of Life Inventory Short Form 15
Quality of Recovery 15
Patient Health Questionnaire
Generalized Anxiety Disorder
Beyond the preview
Full results, competitive context and analysis are in the Gosset platform.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06671002.